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Objectives: Isoﬂurane is a widely used anesthetic in clinical practice and animal experiments. It exerts
cardioprotective effects by pre- and postconditioning but also has dose-dependent cardiovascular side
effects. In this article, we aim to characterize the hemodynamic effects of isoﬂurane.
Materials and methods: We used a pressureevolume catheter to evaluate the hemodynamic changes in
adult SpragueeDawley rats (n ¼ 6) given increasing concentrations of inhaled isoﬂurane anesthesia. The
concentration was started at 0.5% (baseline) and gradually increased. Data on cardiovascular variables
were recorded at each concentration.
Results: Heart rate, blood pressure, and left ventricular systolic and diastolic function decreased as
isoﬂurane concentration increased. At a concentration of 3%, isoﬂurane signiﬁcantly decreased
myocardial contractility, blood pressure, and heart rate, and impaired left ventricular diastolic function.
Conclusion: High-dose isoﬂurane resulted in unfavorable hemodynamics. Old age and dehydration may
predispose animals to the unfavorable hemodynamic effects of isoﬂurane. Determining the optimal
isoﬂurane concentration for anesthesia or preconditioning is important. The effects of isoﬂurane anes-
thesia on aged and/or volume-depleted animals should be further investigated.
Copyright © 2014, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Isoﬂurane is a common inhalational anesthetic in animal ex-
periments and clinical practice. Thus, the cardiovascular charac-
teristics of this agent should be carefully investigated. Isoﬂurane
affects several hemodynamic parameters, which result in various
cardiovascular side effects. It alters cardiac electrophysiological
function and may cause arrhythmia and decrease cardiac contrac-
tility [1,2]. Furthermore, isoﬂurane decreases peripheral vascular
resistance [3], leading to hypotension. Because it is a potent coro-
nary vasodilator, isoﬂurane may, under certain conditions, cause a
coronary steal phenomenon in ischemic regions [4]. However,, Buddhist Tzu Chi General
lien, Taiwan. Tel.: þ886 3
eng).
elief Tzu Chi Foundation. Publisheisoﬂurane also has a dose-dependent cardioprotective effect. It can
protect the heart against ischemiaereperfusion injury and may
limit myocardial infarct size to an extent similar to that seen in
ischemic preconditioning.
The cardioprotective mechanisms of volatile anesthetics have
been extensively studied [5], but the mechanisms responsible for
cardioprotection are not well understood. Phosphatidylinositol 3-
kinase has a role in myocardial protection from both anesthetic
and ischemic preconditioning [6]. Isoﬂurane has been used during
cardiac surgery to exert a preconditioning protective effect [7].
However, the optimal isoﬂurane concentration for preconditioning
may have undesirable hemodynamic effects on patients. Therefore,
the effect of dose dependency on hemodynamics during isoﬂurane
anesthesia should be investigated.
Pressureevolume analysis is a useful approach for examining
in vivo intact ventricular function in all loading conditions. The
reliability and reproducibility of pressureevolume catheters for
simultaneous, real-time measurement of left ventricular (LV)
pressure and volume make them useful for evaluating LV functiond by Elsevier Taiwan LLC. All rights reserved.
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imal studies since the mid-1980s. Recent advances in the devel-
opment and validation of microconductance pressureevolume
catheters have made it possible to use this approach to assess
cardiac and pharmacological interventions in small animals. A
technique for LV pressureevolume analysis in rats was recently
introduced. However, only limited normative data are available [9].
We used a pressureevolume loop system to investigate the
hemodynamic effects of different concentrations of inhalational
isoﬂurane anesthesia in adult rats.
2. Materials and methods
2.1. Animals
Male SpragueeDawley rats (n ¼ 6; age 8e12 months; weight,
about 600 g) were purchased from BioLASCO Co., Ltd. (Taipei,
Taiwan). The rats were kept in cages (2 rats per cage) in our labo-
ratory animal center and fed with standard laboratory diet and tap
water ad libitum on a 12-h/12-h light/dark cycle. All study pro-
cedures were performed in accordance with the guidelines of the
Institutional Animal Care and Use Committee of Tzu Chi University,
Hualien, Taiwan.
2.2. Experimental protocol
Anesthesia induction was performed with a mixture of 5% iso-
ﬂurane and oxygen in an induction chamber. After induction, the
animals were placed on a heating pad in the supine position. A
tracheostomy was performed, and the animals were ventilated
with a mixture of 1.5% isoﬂurane and oxygen by a Harvard rodent
ventilator (Model 683; Harvard Apparatus, Holliston, MA, USA)
during the instrumentation procedure. The ventilator was set at a
tidal volume of 6.2  M1.01 (where M denotes the animal mass in
kg) and a frequency of 70 ventilations/minute. The right carotid
artery was exposed, and a pressureevolume catheter (SPR-901;
Millar Instruments, Inc., Houston, TX, USA) was inserted into it and
advanced into the LV while being guided by real-time pressure and
volume signals. A polyethylene tube was inserted into the left ju-
gular vein for administration of ﬂuids. The signals were continu-
ously recorded by a PowerLab data acquisition system and LabChart
software (AD Instruments, Mountain View, CA, USA). Then, four
different isoﬂurane concentrationsd0.5% (baseline), 1%, 2%, and
3%dwere given as the interventions. The experiment started at an
isoﬂurane concentration of 0.5%, and the concentration was
increased every 3 minutes. Heart rate, blood pressure, maximum
ﬁrst derivative of LV pressure over time (dP/dtmax), and minimum
ﬁrst derivative of LV pressure over time (dP/dt min) were recordedTable 1
Cardiovascular characteristics of rats according to the concentration of isoﬂurane anesth
ISO 0.5% (baseline) ISO 1%
Heart rate (bpm) 325.0 (16.9) 341.0 (29.1)
SBP (mmHg) 154.2 (13.3) 160.0 (26.4)
DBP (mmHg) 118.4 (9.7) 120.0 (24.2)
MAP (mmHg) 130.3 (10.7) 133.3 (24.9)
DBP e Ped (mmHg) 113.1 (10.0) 114.4 (24.1)
Pes (mmHg) 154.5 (14.7) 158.9 (28.5)
Ped (mmHg) 5.3 (2.0) 5.6 (1.4)
dP/dt max (mmHg/s) 10,278.2 (1278.6) 10,321 (717.7)
dP/dt min (mmHg/s) 8009.5 (392.0) 7988.5 (907.8)
Data are presented as mean (SD).
*p < 0.05 versus ISO 0.5% (baseline).
DBP ¼ diastolic blood pressure; ISO ¼ isoﬂurane; MAP ¼ mean arterial pressure; Ped ¼
SBP ¼ systolic blood pressure.continuously at each concentration and compared with values
obtained at other concentrations. Inferior vena cava compression
was performed at every isoﬂurane concentration, and the end-
systolic pressureevolume relation (ESPVR) was recorded.
2.3. Statistical analysis
Descriptive statistics are expressed as means ± standard de-
viations for all hemodynamic variables. The Friedman test was used
to evaluate the effects of different concentrations. A p value of <
0.05 indicated statistical signiﬁcance. If the result was signiﬁcant,
the Dunn post hoc test was used to compare the difference between
the value at baseline and the value at a given isoﬂurane
concentration.
3. Results
3.1. Heart rate
Hemodynamic characteristics, including heart rate, blood pres-
sure, and dP/dt, are shown according to isoﬂurane concentration in
Table 1. The heart rate increased when the isoﬂurane concentration
was increased from 0.5% to 1% and then progressively decreased
with increasing isoﬂurane concentration. The difference in heart
rate at a concentration of 1.5% (standard) versus 0.5% isoﬂurane
(baseline) was not signiﬁcant. However, heart rate signiﬁcantly
differed between the baseline concentration and the concentration
of 3% (high dose; Fig. 1).
3.2. Blood pressure
Systolic blood pressure, diastolic blood pressure, and mean
arterial pressure increased as the isoﬂurane concentration was
increased from 0.5% to 1% and then progressively decreased with
increasing isoﬂurane concentration. As compared with baseline,
these variables were signiﬁcantly lower at a concentration of 3%.
However, LV end-diastolic pressure did not signiﬁcantly change in
relation to isoﬂurane concentration. The difference between dia-
stolic aortic pressure and LV end-diastolic pressure (DBP e Ped),
which represents coronary perfusion pressure, was also signiﬁ-
cantly lower than the baseline value at a concentration of 3%
(p < 0.001).
3.3. Cardiac systolic function
At a concentration of 3%, dP/dt max, the maximum rate of
pressure change in the ventricle, was signiﬁcantly lower than at
baseline. However, dP/dt max is load-dependent and, therefore, aesia.
ISO 1.5% ISO 2% ISO 3%
321.0 (23.4) 278.2 (31.7) 234.8 (21.8)*
126.2 (27.3) 100.4 (25.6) 85.0 (16.1)*
92.6 (33.1) 62.5 (30.1) 49.4 (23.1)*
103.8 (31.1) 75.1 (28.3) 61.3 (20.6)*
86.8 (33.6) 56.8 (29.8) 42.9 (22.3)*
127.8 (27.4) 103.9 (27.9) 86.0 (14.6)*
5.8 (1.6) 5.7 (2.0) 6.6 (2.8)
8424.5 (1784.9) 5782.8 (2249.1) 4312.5 (1315.9)*
6537.3 (1757.2) 4736.0 (1911.8) 3663.2 (1200.6)*
left ventricular end-diastolic pressure; Pes ¼ left ventricular end-systolic pressure;
Fig. 1. Effects of different concentrations of isoﬂurane on hemodynamic variables. Hemodynamic variablesd(A) dP/dt max, (B) dP/dt min, (C) heart rate, and (D) mean arterial
pressuredare expressed as means with standard deviations. All values decreased in a dose-dependent manner as isoﬂurane concentration increased, and values at a concentration
of 3% were signiﬁcantly lower than those at baseline. *p < 0.05 versus ISO 0.5% (baseline).
C.-F. Yang et al. / Tzu Chi Medical Journal 26 (2014) 119e122 121less accurate index of contractility. ESPVR describes the maximal
pressure that can be developed by the ventricle at a given LV vol-
ume. It is relatively insensitive to load and, thus, is a better index of
LV systolic function. ESPVR was signiﬁcantly lower at an isoﬂuraneFig. 2. Change in the pressureevolume loop relation due to change in isoﬂurane concentr
volume loop shifted, and the end-systolic pressureevolume relation (ESPVR) decreased.
signiﬁcantly lower at a concentration of 3%. ESPVR ¼ end-systolic pressureevolume relatioconcentration of 3% than at baseline (p ¼ 0.028; Fig. 2). These
ﬁndings indicate that LV systolic function is impaired when the
isoﬂurane concentration is high. Cardiovascular function improved
when the anesthetic depth was reduced (data not shown).ation. As isoﬂurane concentration increased from (A) 1.5% to (B) 2.5%, the pressuree
As compared with the ESPVR at (C) other isoﬂurane concentrations, the value was
n.
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dP/dt min is valuable for evaluating LV diastolic function and
progressively decreased as isoﬂurane concentration increased. It
was signiﬁcantly lower at a concentration of 3% than at baseline. By
contrast, LV end-diastolic pressure was not signiﬁcantly related to
isoﬂurane concentration (p ¼ 0.298). These results suggest that
isoﬂurane impairs both LV systolic function and LV diastolic func-
tion. However, diastolic impairment was not reﬂected by LV end-
diastolic pressure.4. Discussion
Our results show that isoﬂurane has dose-dependent effects on
cardiac hemodynamics. At a high dose, inhalational isoﬂurane
decreased heart rate, blood pressure, and myocardial contractility.
Previous studies found that although isoﬂurane decreases periph-
eral vascular resistance, it has no effect on myocardial contractility
[3,10].
There are several possible reasons why high-dose isoﬂurane
impairs myocardial contractility. First, through its hypotensive ef-
fects, inhalational isoﬂurane might indirectly suppress the
myocardium. LV end-diastolic pressure was not signiﬁcantly
elevated despite the effect that maximal-concentration isoﬂurane
had on blood pressure. These ﬁndings suggest that the peripheral
vasodilator effect of maximum-concentration isoﬂurane decreased
venous return from the peripheral circulation. However, contrac-
tility could be still impaired because coronary autoregulation
would still be compromised when the mean arterial pressure
dropped to a low level during high-dose isoﬂurane inhalation.
Coronary blood ﬂow is pressure-dependent, and severe hypoten-
sion causes coronary insufﬁciency, leading to myocardial ischemia
and impaired myocardial contractility.
Second, hemodynamic changes at different isoﬂurane concen-
trations could be affected by body ﬂuid status, for example, hypo-
volemic or euvolemic states. In a previous study, at similar
anesthesia concentrations, ﬂuid support lessened the hypotensive
effect of inhaled isoﬂurane in dehydrated animals [11]. However,
another study found that rapid rehydration did not reverse
isoﬂurane-induced hypotension in normovolemic animals [12].
Therefore, dehydrated animals may be more vulnerable to the ef-
fects of anesthetics. It is difﬁcult to measure volume status in rats in
hemodynamic studies. In the present experiment, we did not
routinely provide ﬂuid supplementation during the entire proce-
dure. Thus, the rats might have been dehydrated, and the hypo-
tensive effect of isoﬂurane may have been exaggerated. However,
ESPVR, an independent preload variable, showed that myocardial
contractility decreased with hypotension during high-dose iso-
ﬂurane inhalation.
Third, aging might be another important factor that affects
cardiac hemodynamics at different isoﬂurane concentrations. Pre-
vious studies showed that aging altered cardiac hemodynamics and
function in many ways [13]. As compared with young rats, old rats
have a lower dP/dt max, ejection fraction, and cardiac index, and
higher LV end-diastolic volume and pressure, at the same anes-
thesia concentration [13]. The rats we used in our experiments
were much older than were those used in a previous study [3].
However, it may be better to use old rats in such studies as he-
modynamic characteristics are more likely to be a clinical concernfor older adult humans. In any case, a fundamental understanding
of hemodynamic effects in elderly adults is crucial.
Our study has several limitations. First, coronary ﬂow was not
measured in our experiment. DBP-LV end-diastolic pressure is an
indirect measure of coronary perfusion pressure. An isolated heart
perfusion model may be needed in order to study coronary physi-
ology and its relationships to inhalational isoﬂurane. Second,
SpragueeDawley rats are outbred and could thus have heteroge-
neous responses to inhalational isoﬂurane. Third, to further
examine the effects of isoﬂurane on peripheral vascular resistance
and myocardial contractility, a b antagonist and an a1 antagonist
should be used. Fourth, other physiological variables, including
temperature, pH, and lactate level, could inﬂuence blood pressure
but were not examined in our study.
The present results indicate that administration of high-dose
isoﬂurane causes unfavorable hemodynamics changes, and old
age and dehydration may predispose animals to these undesirable
effects. A better understanding of the hemodynamic effects of
isoﬂurane anesthesia in aged, volume-depleted humans will help
clinicians to avoid the use of unnecessarily high doses of isoﬂurane.
Future research is necessary to identify the optimal dose of iso-
ﬂurane for a preconditioning effect in ischemiaereperfusion injury.
In conclusion, high-dose inhalational isoﬂurane can affect blood
pressure, heart rate, and LV systolic function unfavorably. Careful
monitoring of hemodynamics in patients is indicated when higher
doses of isoﬂurane are given. The dose-dependent effect of inha-
lational isoﬂurane anesthesia on cardiac hemodynamics should be
further examined.
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